Yukiko Okazaki

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki et al. · The Lancet Diabetes & Endocrinology · 2017 · 300 citations

Non-pharmacological Intervention, Diabetes Management, Cardiovascular Disease +9

Adiponectin Enhances Insulin Sensitivity by Increasing Hepatic IRS-2 Expression via a Macrophage-Derived IL-6-Dependent Pathway

Motoharu Awazawa, Kohjiro Ueki, Kazunori Inabe et al. · Cell Metabolism · 2011 · 270 citations · Full text

Inflammation, Metabolic Syndrome, Hepatic Irs-2 Expression +12

CD206+ M2-like macrophages regulate systemic glucose metabolism by inhibiting proliferation of adipocyte progenitors

Allah Nawaz, Aminuddin Aminuddin, Tomonobu Kado et al. · Nature Communications · 2017 · 264 citations · Full text

Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway

Motoharu Awazawa, Kohjiro Ueki, Kazunori Inabe et al. · Biochemical and Biophysical Research Communications · 2009 · 186 citations

Hepatic Srebp1c Expression, Metabolic Syndrome, Signal Transduction +13

The RNA Methyltransferase Complex of WTAP, METTL3, and METTL14 Regulates Mitotic Clonal Expansion in Adipogenesis

Masatoshi Kobayashi, Mitsuru Ohsugi, Takayoshi Sasako et al. · Molecular and Cellular Biology · 2018 · 179 citations · Full text